• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ardelyx, Inc. - Common Stock (NQ:ARDX)

    6.815 -0.055 (-0.80%)
    Streaming Delayed Price Updated: 1:56 PM EST, Feb 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,304,210
    Open 7.010
    Bid (Size) 6.810 (2,700)
    Ask (Size) 6.820 (1,200)
    Prev. Close 6.870
    Today's Range 6.720 - 7.010
    52wk Range 3.210 - 8.400
    Shares Outstanding 103,119,010
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
    Conference call scheduled for 4:30 p.m. Eastern Time 
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Receives New Patent for Tenapanor
    New patent covers IBSRELA® and XPHOZAH® and expires in 2042 
    From Ardelyx, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +10.8%
    +10.8%
    1 Month
    -12.2%
    -12.2%
    3 Month
    +15.3%
    +15.3%
    6 Month
    +17.3%
    +17.3%
    1 Year
    +6.2%
    +6.2%

    More News

    Read More
    News headline image
    First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
    From Ardelyx, Inc.
    Via GlobeNewswire
    Ardelyx Stock Rises Premarket As Piper Sees Over 100% Upside — Says Constipation Drug ‘Stole The Show’ With 2026 Guidance ↗
    Via Stocktwits
    Ardelyx Stock Slips After-Hours As $100M Shelf Filing Sparks Dilution Fears After Strong Q3 ↗
    Via Stocktwits
    News headline image
    Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
    From Equity Insider
    Via GlobeNewswire
    News headline image
    Ardelyx Stock Is Rallying – What Is Making Retail So Bullish? ↗
    Via Stocktwits
    News headline image
    Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
    From Ardelyx, Inc.
    Via GlobeNewswire
    Ardelyx Shares Soar Premarket As CEO Sees Continued Demand For Blockbuster Drug Ibsrela ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For October 30, 2025 ↗
    Via Benzinga
    News headline image
    Ardelyx (ARDX) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗
    Via The Motley Fool
    News headline image
    Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday ↗
    Via Benzinga
    News headline image
    Discover the top movers in Friday's pre-market session. ↗
    Via Chartmill
    News headline image
    Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Top movers in Thursday's after hours session ↗
    Via Chartmill
    News headline image
    Ardelyx Inc (NASDAQ:ARDX) Stock Surges on Q3 2025 Revenue Beat and Raised Guidance ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting
    From Ardelyx, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Ardelyx, Inc. - Common Stock publicly traded?
    Yes, Ardelyx, Inc. - Common Stock is publicly traded.
    What exchange does Ardelyx, Inc. - Common Stock trade on?
    Ardelyx, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ardelyx, Inc. - Common Stock?
    The ticker symbol for Ardelyx, Inc. - Common Stock is ARDX on the Nasdaq Stock Market
    What is the current price of Ardelyx, Inc. - Common Stock?
    The current price of Ardelyx, Inc. - Common Stock is 6.815
    When was Ardelyx, Inc. - Common Stock last traded?
    The last trade of Ardelyx, Inc. - Common Stock was at 02/17/26 01:56 PM ET
    What is the market capitalization of Ardelyx, Inc. - Common Stock?
    The market capitalization of Ardelyx, Inc. - Common Stock is 702.76M
    How many shares of Ardelyx, Inc. - Common Stock are outstanding?
    Ardelyx, Inc. - Common Stock has 703M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.